Mahonia aquifolium extract

Drug Profile

Mahonia aquifolium extract

Alternative Names: Oregon grape extract; Primaderm

Latest Information Update: 19 Jul 1999

Price : $50

At a glance

  • Originator Prime Pharmaceutical Corporation
  • Class Antipsoriatics; Isoquinolines
  • Mechanism of Action 5-lipoxygenase inhibitors; Antioxidants; Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Psoriasis

Most Recent Events

  • 19 Jul 1999 A study in patients with psoriasis has been added to the adverse events and therapeutic trials sections
  • 30 Jun 1999 Launched for Psoriasis in Canada (Topical)
  • 30 Jun 1999 Launched for Psoriasis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top